-
Most Popular
Search Results
240 results for dgse
This Is Why I’d Still Avoid IBio for Now
With no real vaccine news to speak of, I’d avoid the IBIO stock for now. If they can get something going, it may be worth…
Why the New Covid-19 Strain Matters for Pfizer Stakeholders
With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic’s winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some…
NVAX Stock: The Huge Covid-19 News Helping Novavax Shoot Higher
NVAX stock is soaring today as the company announces its intention to supply the European Union with much-needed coronavirus vaccines.
Pfizer News: PFE Stock Surges 4% on Positive Covid-19 Vaccine Results
Pfizer (PFE) news for Wednesday concerning one of its vaccines designed to treat the novel coronavirus has PFE stock taking off.
Sorrento Therapeutics News: SRNE Stock Skyrockets 172% on Claims of ‘COVID-19 Cure’
Sorrento Therapeutics (SRNE) news for Friday concerning a possible cure for the novel coronavirus has SRNE stock soaring.
Inovio Pharmaceuticals News: INO Stock Rockets 12% on Accelerated Coronavirus Vaccine Timeline
Inovio Pharmaceuticals (INO) news for Wednesday concerning a vaccine for the coronavirus from China has INO stock skyrocketing.
OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today
OCGN stock is gaining Wednesday morning on news that Bharat Biotech’s COVAXIN has an overall 78% efficacy rate. Here’s what to know.
At This Point, Go Ahead and Count Inovio Pharmaceuticals Out of the Vaccine Race
INO stock is a purely speculative bet. I don’t see the company being among the few that deliver a vaccine against Covid-19.
Why iBio Stock May Double or Triple in Value
IBIO stock is a potentially rewarding stock if customers use its manufacturing processes to scale up production of a Covid-19 vaccine.
Aimmune’s Prospects Shine After the FDA Approves Its Allergy Drug
Aimmune Therapeutics received FDA approval for its peanut allergy drug Palforzia, and AIMT stock could soar in 2020.
The CDC Just Gave Novavax (NVAX) Stock a Big Boost
Novavax stock is up 6% today after the U.S. Centers for Disease Control and Prevention (CDC) approved its two-dose Covid-19 vaccine for use in adults.
For ChargePoint Stock, Earnings Suddenly Are Crucial
Amid an EV selloff, CHPT stock has plunged. Though Q4 won’t determine its long-term outlook, CHPT and the sector need a dose of optimism.
Aggressive Investors Have No Excuse for Not Owning Moderna
Canada just ordered 20 million doses of Moderna’s Covid-19 vaccine. That’s excellent news for anyone who owns MRNA stock, Canadians included.
Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?
Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.
ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials.
NVAX Stock: Why Novavax Stock Is Down Today Despite Latest Vaccine News
NVAX stock is losing today, even with two big announcements this morning. Speculators seem to think these announcements will lead to delays.
GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q1 2024
GVP stock results show that GSE Systems beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q4 2023
GVP stock results show that GSE Systems beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Why Is Altimmune (ALT) Stock Up 43% Today?
Altimmune stock is rising higher on Friday with heavy trading of ALT shares after posting positive results form a clinical trial.
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?
Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update.
9 – 10 of 240 results
